Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405438
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-05-05
Brief Title:
Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome
Sponsor:
Beylikduzu State Hospital
Organization:
Beylikduzu State Hospital
Study Overview
Official Title:
Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome A Randomized Prospective Clinical Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome Patients receive either 2 weeks of peloid therapy or 15 sessions of paraffin treatment along with splint therapy for 3 months Pain and symptom severity are assessed using the Visual Analog Scale VAS and Boston Carpal Tunnel Syndrome Questionnaire BCTQ Results are measured at baseline 4 weeks post-treatment and a 12-week follow-up
Detailed Description:
This study aims to compare the effectiveness of peloid therapy and paraffin treatment in patients with carpal tunnel syndrome through a randomized prospective clinical trial Prior to treatment electrophysiological evaluations will be conducted and pain severity will be assessed using the Visual Analog Scale VAS The Boston Carpal Tunnel Syndrome Questionnaire BCTQ will be utilized to evaluate the type and severity of symptoms Patients will be randomly divided into two groups one group will receive peloid therapy for 2 weeks administered on consecutive days for 5 days a week while the other group will receive paraffin treatment for a total of 15 sessions administered 5 days a week Additionally both groups will be advised to use splint therapy especially at night for a duration of 3 months VAS scores BCTQ scores and electrophysiological evaluations including median nerve distal motor latency MMNDL median nerve distal sensory latency MNSDL sensory nerve conduction velocity SNCV compound muscle action potential CMAP and sensory nerve action potential SNAP amplitudes will be recorded at baseline 4 weeks post-treatment and at the 12-week follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None